CareFusion — Q1 FY2012 Earnings Presentation
15 slides from CareFusion's earnings presentation, Nov 7, 2011
Slide 1: Q1 Fiscal 2012 Investor/Analyst Call
Q1 Fiscal 2012 Investor/Analyst Call November 7, 2011 Exhibit 99.2
Slide 2: Forward-Looking Statements, GAAP Reconciliation and New Reporting Segments
Forward-Looking Statements, GAAP Reconciliation and New Reporting Segments statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. The matters discussed in these forward-looking statements are subject to risks and uncertaintie
Slide 3: Agenda
New Reporting Segments Q1 Fiscal 2012 Results Updated Fiscal 2012 Guidance Agenda
Slide 4: New Reporting Segments
New Reporting Segments
Slide 5: CareFusion Previously Reported Under Two Segments
Critical Care Technologies • Dispensing • Infusion • Respiratory CareFusion Previously Reported Under Two Segments Medical Technologies & Services • Infection Prevention • Medical Specialties
Slide 6: New Reporting Segments
Medical Systems • Dispensing Technologies • Infusion Systems Infusion Pumps and Dedicated Disposables • Respiratory Technologies Ventilators and Dedicated Disposables • Other MedMined™ Data Mining Surveillance Service In July 2011, realigned organization into two new global segments with new operati
Slide 7: Disclosures By Segment
Medical Systems Procedural Solutions Disclosures By Segment Revenue and Segment Profit Disclosures For: Revenue Disclosures For: • Dispensing Technologies • Infusion Systems • Respiratory Technologies • Other • Infection Prevention • Medical Specialties • Specialty Disposables • Other
Slide 8: Q1 Fiscal 2012 Results
Q1 Fiscal 2012 Results
Slide 9: Quarterly Review
GAAP Adjusted $M $M % Change % Change 1 1 Q1 FY12 Year-Over-Year Quarterly Review Revenue $844 4% $844 4% Operating Expenses $319 (4)% $308 4% Operating Income $108 37% $119 1% Income from Continuing Operations $67 86% $76 19% Diluted EPS from Continuing Operations $0.30 76% $0.33 14% % Change over
Slide 10: Quarterly Segment Review
GAAP Adjusted Medical Systems $M % Change $M % Change Procedural Solutions $M % Change $M % Change 1 1 1 1 Q1 FY12 Year-Over-Year Quarterly Segment Review Revenues $509 9% $509 9% Segment Profit $88 29% $95 6% Revenues $335 (2)% $335 (2)% Segment Profit $20 82% $24 (14)% % Change over prior year per
Slide 11: Quarterly Sub-Segment Revenues
$ in millions Q1 FY12 Q1 FY11 % Change Q1 FY12 Year-Over-Year Quarterly Sub-Segment Revenues Medical Systems $509 $468 9% Dispensing Technologies $237 $205 16% Infusion Systems $206 $192 7% Respiratory Technologies $60 $65 (8)% Other $6 $6 - % Procedural Solutions $335 $343 (2)% Infection Prevention
Slide 12: Updated Fiscal 2012 Guidance
Updated Fiscal 2012 Guidance
Slide 13: Updated FY12 Financial Guidance
Previous FY12 Outlook 1 Updated FY12 Outlook 2 Updated FY12 Financial Guidance November 7, 2011 Total Revenue 3-5% growth over FY11 revenue of $3.5B on a constant currency basis 3-5% growth over FY11 revenue of $3.5B on a constant currency basis Adjusted Operating Margin ³ ~18% ~18% Adjusted Effecti
Slide 14: Q&A
Q&A
Slide 15: Q1 FY12 Non-GAAP Reconciliations
$ in millions Q1 FY12 GAAP Nonrecurring Items 1 Q1 FY12 Adjusted 1 Q1 FY12 Non-GAAP Reconciliations Operating Expenses $319 $(11) $308 Operating Income $108 $11 $119 Income From Continuing Operations $67 $9 $76 Diluted EPS From Continuing Operations $0.30 $0.04 $0.33 Medical Systems Segment Profit $